Edwards R M, Trizna W
SmithKline Beecham Pharmaceuticals, Department of Renal Pharmacology, King of Prussia, Pennsylvania, USA.
J Pharmacol Exp Ther. 1995 Sep;274(3):1084-9.
We characterized 125I-ET-1 binding to renal microvascular membranes isolated from the rat, a species showing ETB receptor-mediated renal vasoconstriction, and the rabbit in which ET-induced renal vasoconstriction is mediated by the ETA receptor. In both species, 125I-ET-1 bound in a manner consistent with a single high-affinity site. Scatchard analysis yielded Kd and Bmax values of 20.1 +/- 0.4 pM and 1343 +/- 64 fmol/mg for the rat and 21.5 +/- 0.9 pM and 810 +/- 64 fmol/mg for the rabbit. Competition binding studies with several selective (sarafotoxin 6c, BQ123) and mixed ETA/ETB (SB 209670) ET receptor ligands showed that the renal microvasculature from both species contain ETA and ETB receptors in a proportion of 40:60. In the rat, the proportion of ETA receptors was higher in the microvasculature than in glomeruli and inner medullary collecting duct cells both of which contained > 80% ETB receptors. In the rabbit, the proportion of ETA/ETB receptors was similar in the microvasculature and inner medullary collecting duct cells (approximately 40:60), whereas glomeruli contained 80% ETB receptors. Although ET-induced renal vasoconstriction in the rat and rabbit is mediated by different ET receptor subtypes, the proportion of ETA to ETB receptors is the same in the renal microvasculature from these species.
我们对从大鼠(一种显示ETB受体介导肾血管收缩的物种)和兔子(ET诱导的肾血管收缩由ETA受体介导)分离出的肾微血管膜上的125I-ET-1结合进行了表征。在这两个物种中,125I-ET-1均以与单一高亲和力位点一致的方式结合。Scatchard分析得出大鼠的Kd和Bmax值分别为20.1±0.4 pM和1343±64 fmol/mg,兔子的Kd和Bmax值分别为21.5±0.9 pM和810±64 fmol/mg。用几种选择性(sarafotoxin 6c、BQ123)和混合的ETA/ETB(SB 209670)ET受体配体进行的竞争结合研究表明,这两个物种的肾微血管中ETA和ETB受体的比例均为40:60。在大鼠中,微血管中ETA受体的比例高于肾小球和内髓集合管细胞,后两者均含有>80%的ETB受体。在兔子中,微血管和内髓集合管细胞中ETA/ETB受体的比例相似(约为40:60),而肾小球含有80%的ETB受体。尽管大鼠和兔子中ET诱导的肾血管收缩由不同的ET受体亚型介导,但这些物种肾微血管中ETA与ETB受体的比例相同。